858 Therapeutics last raised $25.2M in its Early Stage VC (Jun 2024).
- ·Watch 858 Therapeutics: the Monday email on marks, rounds and moves
858 Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Early Stage VC | $25.2M | ▮ | ▮ |
| May 2021 | Early Stage VC | $20.0M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $20.1M | ▮ | ▮ |
Membership and data by Private Market View
858 Therapeutics valuation
858 Therapeutics's last known valuation is $140 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has 858 Therapeutics raised?
858 Therapeutics has raised $110 million across 3 recorded rounds since 2020. The largest was a $25.2 million early-stage round in Jun 2024.
858 Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2024 ($25.2 million sold to 12 investors).
How 858 Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For 858 Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about 858 Therapeutics
- What is 858 Therapeutics worth?
- 858 Therapeutics's last known valuation is $140.0M.
- How much has 858 Therapeutics raised?
- 858 Therapeutics has raised $110.0M in total funding across 3 recorded rounds.
- When did 858 Therapeutics last raise?
- 858 Therapeutics last raised in Jun 2024 (Early Stage VC), raising $25.2M.